Table 2.
Volume reduction of fibroadenomas after HIFU-intervention.
| Visit | FUa | Pts/FAb | Volumec (mm3) | VRRd (%) | VRRe (%) |
|---|---|---|---|---|---|
| V1 | D0 | 27/27 | 1083.10 ± 801.02 | – | – |
| V2 | D7 | 27/27 | 1244.53 ± 1317.63 | − 9.64% ± 70.60% | − 9.67% ± 72.00% |
| V3 | M6 | 27/27 | 347.13 ± 389.22 | 61.63% ± 47.21% | 62.30% ± 48.01% |
| V4 | M12 | 27/27 | 203.15 ± 316.21 | 84.81% ± 17.35% | 86.44% ± 15.45% |
| V5 | M24 | 26/26 | 117.16 ± 260.44 | 92.04% ± 15.66% | 94.44% ± 9.95% |
| V6 | M36 | 21/21 | 124.29 ± 282.00 | 92.05% ± 16.35% | 94.90% ± 10.07% |
| V7 | M60 | 25/25 | 129.65 ± 465.27 | 92.17% ± 29.09% | 97.85% ± 6.41% |
The data represent the mean values ± SD for the variables Volume and VRR (Volume Reduction Rate).
aThe follow-up (FU) was conducted during visits (V1-V7) on Day 0 (D0), Day 7 (D7) post-HIFU, and at 6, 12, 24, 36, and 60 months (M6, M12, M24, M36, M60) after the HIFU intervention.
bNumber (n) of examined patients (Pts) and fibroadenomas (FA) at each visit (V1-V7).
cVolume (mean ± SD) of fibroadenomas before HIFU (V1) and after HIFU at visits V2-V7.
dVolume Reduction Rate (VRR) in % (mean ± SD) of fibroadenomas after HIFU at visits V2-V7.
eVolume Reduction Rate (VRR) in % (mean ± SD) of fibroadenomas after HIFU at visits V2-V7 after excluding patient No.22.